- Home
- Pathology Industry
- Hormone Market and Forecasts, May 2013
Industries
- Pathology (329)
- Drug and Medication (297)
- Fruit and Vegetable (152)
- Agrochemical (100)
- Biotechnology (93)
-
- Agriculture (86)
- Meat and Poultry (82)
- Fish and Seafood (80)
- Biopharmaceutical (68)
- Energy & Environment (65)
- Dairy Products and Egg (61)
- Skin Care Products (56)
- Water Distribution and Treatment (56)
- Food (47)
- Pesticide (47)
- Fertilizer (45)
- Livestock (39)
- Genomics (31)
- In Vitro Diagnostic (30)
- Diagnostics (29)
Top countries
- United States (785)
- India (225)
- World (159)
- Canada (134)
- China (126)
-
- Australia (104)
- Europe (90)
- Ireland (51)
- United Kingdom (50)
- Japan (39)
- Germany (39)
- Brazil (34)
- Iran (31)
- Nigeria (26)
- Malaysia (25)
- Africa (24)
- Pakistan (23)
- South Africa (22)
- Italy (22)
- Russian Federation (22)
Publication dates
All regions
-
- Algeria (2)
- Benin (2)
- Botswana (1)
- Cameroon (1)
- Chad (1)
- Egypt (17)
- Ethiopia (7)
- Gambia (1)
- Ghana (5)
- Kenya (5)
- Libyan Arab Jamahiriya (1)
- Madagascar (1)
- Malawi (1)
- Mauritius (3)
- Morocco (2)
- Namibia (5)
- Niger (2)
- Nigeria (26)
- Rwanda (1)
- Sierra Leone (1)
- South Africa (22)
- Sudan (2)
- Swaziland (3)
- Tanzania (3)
- Tunisia (1)
- Zambia (1)
- Zimbabwe (2)
-
- Afghanistan (1)
- Armenia (1)
- Azerbaijan (1)
- Bangladesh (8)
- Bhutan (1)
- China (126)
- Georgia (7)
- India (225)
- Indonesia (11)
- Iran (31)
- Iraq (2)
- Israel (6)
- Japan (39)
- Jordan (3)
- Kazakhstan (2)
- Laos (1)
- Lebanon (4)
- Malaysia (25)
- Myanmar (1)
- Nepal (1)
- Oman (1)
- Pakistan (23)
- Philippines (21)
- Saudi Arabia (12)
- Singapore (11)
- South Korea (18)
- Sri Lanka (2)
- Syrian Arab Republic (1)
- Taiwan (7)
- Thailand (20)
- Turkey (18)
- Vietnam (7)
-
- Albania (1)
- Austria (3)
- Belgium (8)
- Bulgaria (3)
- Croatia (1)
- Cyprus (1)
- Czech Republic (6)
- Denmark (16)
- Estonia (1)
- Finland (12)
- France (18)
- Germany (39)
- Greece (9)
- Hungary (2)
- Iceland (4)
- Ireland (51)
- Italy (22)
- Latvia (1)
- Lithuania (3)
- Luxembourg (1)
- Macedonia (5)
- Netherlands (12)
- Norway (8)
- Poland (7)
- Portugal (1)
- Romania (5)
- Russian Federation (22)
- San Marino (1)
- Serbia and Montenegro (4)
- Slovenia (1)
- Spain (13)
- Sweden (10)
- Switzerland (14)
- Ukraine (2)
- United Kingdom (50)
-
- Australia (104)
- Austria (3)
- Belgium (8)
- Canada (134)
- Chile (7)
- Czech Republic (6)
- Denmark (16)
- Estonia (1)
- Finland (12)
- France (18)
- Germany (39)
- Greece (9)
- Hungary (2)
- Iceland (4)
- Ireland (51)
- Israel (6)
- Italy (22)
- Japan (39)
- Luxembourg (1)
- Mexico (3)
- Netherlands (12)
- New Zealand (10)
- Norway (8)
- Poland (7)
- Portugal (1)
- Slovenia (1)
- South Korea (18)
- Spain (13)
- Sweden (10)
- Switzerland (14)
- Turkey (18)
- United Kingdom (50)
- United States (785)
data types
- All
- Industry Data
- Company Data (1 303)
- Country Data (609)
Hormone Market and Forecasts, May 2013
You might be interested in: diabete, insulin, breast cancer, more »
industry reports
country reports
Hormone Market in The United States
- Industry report
- January 2012
- 3 pages
... In the public sector regarding the safety of consuming hormone implanted beef. In short, the use of supplemental hormones in beef production has been scientifically proven as safe for consumers and is approved ...
- Industries: Drug and Medication
- Countries: United States
The Brazilian Hormone Industry Brief
- Industry report
- May 2012
- 6 pages
... Of hormones retention times. Therefore blank samples (ultrapure water) were injected with and without addition of mixed standard. Linearity was evaluated by the response obtained as a function of analyte ...
- Industries: Drug and Medication
- Countries: Brazil
The Indonesian Hormone Industry Brief
- Industry report
- October 2011
- 6 pages
... Hydroxy-5alpha contents of s. Androgynus leaves are also involved in female progesterone (p4) and estradiol-17 (E2) steroid hormones secretion. Steroid hormones such as e2 and p4 are important ...
- Industries: Drug and Medication
- Countries: Indonesia
Hormone Business Brief
- Industry report
- December 2011
- 6 pages
... Such as osteoarthrosis. Adverse reactions of thyroid hormones are generally associated with excessive dosage and correspond to the symptoms of hyperthyroidism. See also section 4.10. 4.7. Use during pregnancy ...
- Industries: Drug and Medication
Hormone Market Brief
- Industry report
- December 2011
- 6 pages
... Such as osteoarthrosis. Adverse reactions of thyroid hormones are generally associated with excessive dosage and correspond to the symptoms of hyperthyroidism. See also section 4.10. 4.7. Use during pregnancy ...
- Industries: Drug and Medication
Hormone Sector Brief
- Industry report
- December 2011
- 6 pages
... Such as osteoarthrosis. Adverse reactions of thyroid hormones are generally associated with excessive dosage and correspond to the symptoms of hyperthyroidism. See also section 4.10. 4.7. Use during pregnancy ...
- Industries: Drug and Medication
Hormone Market in Ireland
- Industry report
- November 2011
- 5 pages
... If ingested. 4.6 Adverse reactions (frequency and seriousness) restoration of physical activity may unmask or intensify other problems, such as osteoarthrosis. Adverse reactions of thyroid hormones ...
- Industries: Drug and Medication
- Countries: Ireland
Hormone Sector in Ireland
- Industry report
- November 2011
- 5 pages
... If ingested. 4.6 Adverse reactions (frequency and seriousness) restoration of physical activity may unmask or intensify other problems, such as osteoarthrosis. Adverse reactions of thyroid hormones ...
- Industries: Drug and Medication
- Countries: Ireland
Hormone Sector in Ireland
- Industry report
- July 2012
- 8 pages
... Examinations. As a number of patients show elevated concentrations of t4 and ft4, basal serum concentration of thyroid-stimulating hormone provides a more reliable basis for following treatment course. Patients ...
- Industries: Drug and Medication
- Countries: Ireland
Hormone Market in The United States
- Industry report
- June 2011
- 14 pages
- by Corporation
... Chemicals Called endocrine disrupting chemicals (edcs) Expose humans with potential harmful influences on health and hormone regulation. As recently reviewed, several of these edcs have been found to have ...
- Industries: Drug and Medication
- Countries: United States
» Purchase Premium Reports (From $ 125 - $ 24 988)
About 700 reports for Hormone
The U.S. Market for Rx to OTC Switches, 6th Edition
- $ 3 995
- Industry report
- January 2013
- by Kalorama Information
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription. This report ...
» Read our Company Profiles
4 Companies for HormoneBig Island Tropical Flower Farms
United StatesCitrix
United StatesAccessEd
AustraliaMaterials and Methods
United StatesReportlinker.com © Copyright 2013. All rights reserved.
